American College of Clinical Pharmacy ®

SCHEDULE

ACCP Awards and Recognition Ceremony

Sunday, November 12, 2023 from 8:00 AM to 11:45 AM CST at Lone Star Ballroom B

Welcome

8:00 AM to 8:05 AM

Speaker: Elizabeth A. Farrington, Pharm.D., B.S.Pharm, FCCP, FCCM, FPPA, BCNSP, BCPPS, BCPS
Title: Clinical Pharmacist - Pediatrics
Institution: New Hanover Regional Medical Center
City/State: Wilmington, NC
View Biography

New Educator Award

8:00 AM to 8:15 AM

Award Winner: Paul M. Boylan, Pharm.D., BCPS
Title: Assistant Professor
Institution: The University of Oklahoma College of Pharmacy
City/State: Oklahoma City, OK
View Biography

New Clinical Practitioner Award

8:15 AM to 8:25 AM

Award Winner: Wesley D. Kufel, Pharm.D., BCIDP, BCPS, AAHIVP
Title: Clinical Associate Professor
Institution: Binghamton University School of Pharmacy and Pharmaceutical Sciences
City/State: Camillus, NY
View Biography

New Investigator Award/Lecture — Rationally Optimized Antibiotic Combinations for Carbapenem-Resistant Klebsiella pneumoniae

8:25 AM to 8:45 AM

Available for 0.25 hours of CPE credit
Activity Number: 0217-0000-23-190-L01-P
Activity Type: A Knowledge-Based Activity

Infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp) are an urgent public health threat since they are associated with mortality rates of up to 34% and treatment options are very limited. Antibiotic combinations are frequently employed to treat CR-Kp. However, the approach for choosing antibiotics and dosing regimens to use in combinations to treat infections caused by CR-Kp have not been rationally optimized. This lecture will discuss new approaches to selecting antibiotics for combination therapy treatment of CR-Kp infections.

Award Winner: Zackery P. Bulman, Pharm.D.
Title: Assistant Professor
Institution: University of Illinois at Chicago
City/State: Chicago, IL
View Biography

Learning Objectives

1. Describe the limitations of current treatment options for serious infections caused by carbapenem-resistant Klebsiella pneumonia.

2. Discuss the benefits of identifying bacterial resistance genes to provide patient-specific therapy through molecular rapid diagnostics.

3. Identify alternative combination treatment strategies for carbapenem-resistant Klebsiella pneumoniae.

Education Award

8:45 AM to 8:55 AM

Award Winner: Angela Shogbon Nwaesei, Pharm.D., BCPS
Title: Clinical Professor
Institution: Mercer University College of Pharmacy
City/State: Lilburn, GA
View Biography

Clinical Practice Award

8:55 AM to 9:05 AM

Award Winner: Sonak Pastakia, Pharm.D., Ph.D., MPH, FCCP
Title: Professor
Institution: Purdue University
City/State: Indianapolis, IN
View Biography

Russell R. Miller Award

9:05 AM to 9:15 AM

Award Winner: Manjunath P. Pai, Pharm.D.
Title: Professor and Chair
Institution: University of Michigan, College of Pharmacy
City/State: Ypsilanti, MI
View Biography

Robert M. Elenbaas Service Award

9:15 AM to 9:25 AM

Award Winner: J. Herbert Patterson, Pharm.D., FCCP
Title: Professor of Pharmacy
Institution: University of North Carolina
City/State: Chapel Hill, NC
View Biography

Warren E. Weaver/Richard P. Penna Award

9:25 AM to 9:35 AM

Award Winner: Elizabeth A. Farrington, Pharm.D., B.S.Pharm, FCCP, FCCM, FPPA, BCNSP, BCPPS, BCPS
Title: Clinical Pharmacist - Pediatrics
Institution: New Hanover Regional Medical Center
City/State: Wilmington, NC
View Biography

Paul F. Parker Medal Award

9:35 AM to 9:45 AM

Award Winner: Bradley A. Boucher, Pharm.D., FCCP, FNAP, MCCM
Title: Professor of Clinical Pharmacy and Translational Science
Institution: College of Pharmacy, University of Tennessee Health Science Center
City/State: Collierville, TN
View Biography

Break

9:45 AM to 9:55 AM

Outgoing President's Address

9:55 AM to 10:15 AM

Incoming President’s Address

10:15 AM to 10:35 AM

Speaker: Brian A. Hemstreet, Pharm.D., FCCP, BCPS
Title: Associate Dean for Student Affairs, Professor
Institution: University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
City/State: Aurora, CO
View Biography

Therapeutic Frontiers Lecture — Expanding our Understanding and Stewardship of Drug Related Kidney Diseases

10:35 AM to 11:10 AM

Available for 0.50 hours of CPE credit
Activity Number: 0217-0000-23-195-L05-P
Activity Type: A Knowledge-Based Activity

Acute kidney injury (AKI) occurs in up to 22% of hospitalized patients and 65% of critically ill patients. Drugs contribute to approximately 30% of AKI cases in hospitalized patient. The incidence and patient outcomes associated with drug-associated AKI (D-AKI) is concerning and diligent surveillance is needed. Understanding D-AKI begins with standardized definitions and classification framework ensure consistency. Developing a comprehensive nephrotoxin stewardship program will provide structured prevention and management strategies. This presentation emphasizes a fundamental understanding of what D-AKI is and approaches for stewardship.

Award Winner: Sandra L. Kane-Gill, Pharm.D., FCCP
Title: Professor
Institution: University of Pittsburgh
City/State: Pittsburgh, PA
View Biography

Learning Objectives

1. Review the contemporary definitions and classification framework for drug related kidney diseases.

2. Summarize the goals of nephrotoxin stewardship.

3. Explain hypervigilance and early detection of drug related kidney diseases as an approach to nephrotoxin stewardship.

ACCP Foundation

11:10 AM to 11:25 AM

Speaker: Jeffrey R. Bishop, Pharm.D., MS, FCCP, BCPP
Title:
Institution: University of Minnesota
City/State: Minneapolis, MN
View Biography

Pharmacotherapy Publications, Inc: Pharmacotherapy and JACCP

11:25 AM to 11:30 AM

Speaker: James E. Tisdale, Pharm.D., FCCP, BCPS
Title: Professor
Institution: Purdue University
City/State: Indianapolis, IN
View Biography

Recognition of New Fellows

11:30 AM to 11:45 AM